You need JavaScript to view this

Attenuation correction in pulmonary and myocardial single photon emission computed tomography

Abstract

The objective was to develop and validate methods for single photon emission computed tomography, SPECT, allowing quantitative physiologic and diagnostic studies of lung and heart. A method for correction of variable attenuation in SPECT, based on transmission measurements before administration of an isotope to the subject, was developed and evaluated. A protocol based upon geometrically well defined phantoms was developed. In a mosaic pattern phantom count rates were corrected from 39-43% to 101-110% of reference. In healthy subjects non-gravitational pulmonary perfusion gradients observed without attenuation correctionwere artefacts caused by attenuation. Pulmonary density in centre of right lung, obtained from the transmission measurement, was 0.28 {+-} 0.03 g/ml in normal subjects. Mean density was lower in large lungs compared to smaller ones. We also showed that regional ventilation/perfusion ratios could be measured with SPECT, using the readily available tracer {sup 133}Xe. Because of the low energy of {sup 133}Xe this relies heavily upon attenuation correction. A commercially available system for attenuation correction with simultaneous emission and transmission, considered to improve myocardial SPECT, performed erroneously. This could lead to clinical misjudgement. We considered that manufacturer-independent pre-clinical tests are required. In a test of two other commercial systems, based on different principles, an  More>>
Authors:
Publication Date:
Jan 01, 2000
Product Type:
Thesis/Dissertation
Report Number:
LUMEDW-MEFL-1014
Reference Number:
EDB-00:108979
Resource Relation:
Other Information: TH: Doctoral diss. (MD); 49 refs, 8 figs, 4 tabs; PBD: Jan 2000
Subject:
62 RADIOLOGY AND NUCLEAR MEDICINE; ATTENUATION; HEART; LUNGS; PERFUSED TISSUES; SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY; XENON 133
OSTI ID:
20057437
Research Organizations:
Lund Univ. (Sweden). Dept. of Clinical Physiology
Country of Origin:
Sweden
Language:
English
Other Identifying Numbers:
TRN: SE0000166018524
Availability:
Available from INIS in electronic form
Submitting Site:
SWDN
Size:
116 pages
Announcement Date:
Dec 18, 2000

Citation Formats

Almquist, H. Attenuation correction in pulmonary and myocardial single photon emission computed tomography. Sweden: N. p., 2000. Web.
Almquist, H. Attenuation correction in pulmonary and myocardial single photon emission computed tomography. Sweden.
Almquist, H. 2000. "Attenuation correction in pulmonary and myocardial single photon emission computed tomography." Sweden.
@misc{etde_20057437,
title = {Attenuation correction in pulmonary and myocardial single photon emission computed tomography}
author = {Almquist, H}
abstractNote = {The objective was to develop and validate methods for single photon emission computed tomography, SPECT, allowing quantitative physiologic and diagnostic studies of lung and heart. A method for correction of variable attenuation in SPECT, based on transmission measurements before administration of an isotope to the subject, was developed and evaluated. A protocol based upon geometrically well defined phantoms was developed. In a mosaic pattern phantom count rates were corrected from 39-43% to 101-110% of reference. In healthy subjects non-gravitational pulmonary perfusion gradients observed without attenuation correctionwere artefacts caused by attenuation. Pulmonary density in centre of right lung, obtained from the transmission measurement, was 0.28 {+-} 0.03 g/ml in normal subjects. Mean density was lower in large lungs compared to smaller ones. We also showed that regional ventilation/perfusion ratios could be measured with SPECT, using the readily available tracer {sup 133}Xe. Because of the low energy of {sup 133}Xe this relies heavily upon attenuation correction. A commercially available system for attenuation correction with simultaneous emission and transmission, considered to improve myocardial SPECT, performed erroneously. This could lead to clinical misjudgement. We considered that manufacturer-independent pre-clinical tests are required. In a test of two other commercial systems, based on different principles, an adapted variant of our initial protocol was proven useful. Only one of the systems provided correct emission count rates independently on phantom configuration. Errors in the other system were related to inadequate compensation of the influence of emission activity on the transmission study.}
place = {Sweden}
year = {2000}
month = {Jan}
}